Compare HQH & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HQH | AZTA |
|---|---|---|
| Founded | 1986 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Industrial Machinery/Components |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 1996 |
| Metric | HQH | AZTA |
|---|---|---|
| Price | $21.80 | $30.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $40.60 |
| AVG Volume (30 Days) | 179.1K | ★ 710.3K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | N/A | ★ $593,821,000.00 |
| Revenue This Year | N/A | $6.99 |
| Revenue Next Year | N/A | $5.98 |
| P/E Ratio | $20.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.36 | $15.93 |
| 52 Week High | $24.85 | $41.73 |
| Indicator | HQH | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 40.95 |
| Support Level | $18.72 | $27.00 |
| Resistance Level | $22.29 | $37.86 |
| Average True Range (ATR) | 0.39 | 1.27 |
| MACD | -0.23 | -0.66 |
| Stochastic Oscillator | 0.19 | 4.33 |
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.